AUTHORS: D’Souza, Ryan S. MD et al Anesthesia & Analgesia: January 2022 – Volume 134 – Issue 1 – p 35-43 BACKGROUND: Intrathecal drug delivery systems (IDDS) have been utilized for over 3 decades for management of chronic pain and spasticity. Patients with IDDS may present for surgical procedures unrelated to the IDDS device, although data […]
Read MoreAuthor: Erika Powers DG News Young children who are exposed to general anaesthesia do not appear to have long-term adverse neurodevelopmental outcomes, according to a study presented at Anesthesiology 2021, the Annual Meeting of the American Society of Anesthesiologists (ASA). Yu Shi, MD, Mayo Clinic, Rochester, Minnesota, and colleagues assessed 33 girls and 28 boys […]
Read MoreAUTHORS: Tyagi, Asha MD et al Anesthesia & Analgesia: February 2022 – Volume 134 – Issue 2 – p 303-311 BACKGROUND: Oxytocin administration during cesarean delivery is the first-line therapy for the prevention of uterine atony. Patients with preeclampsia may receive magnesium sulfate, a drug with known tocolytic effects, for seizure prophylaxis. However, no study has […]
Read MoreAUTHORS: Naik, Bhiken I. MBBCh et al Anesthesia & Analgesia: January 2022 – Volume 134 – Issue 1 – p 8-17 BACKGROUND: Opioids remain the primary mode of analgesia intraoperatively. There are limited data on how patient, procedural, and institutional characteristics influence intraoperative opioid administration. The aim of this retrospective, longitudinal study from 2012 to 2016 […]
Read MoreDG News To help neurologists and other doctors determine the best treatment for people with diabetic neuropathy, the American Academy of Neurology (AAN) has issued a guideline on oral and topical treatments for painful diabetic neuropathy. The guideline is published in Neurology and is endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine. “Living with pain […]
Read More